← Back to Analyst Consensus 
CARL Buy
CARLSMED, INC.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 1 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Sep 28, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Aug 6, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jul 1, 2026 | Needham | initiate | — → Buy | — | 50% |
| May 6, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Apr 15, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Apr 9, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Dec 15, 2025 | BTIG | reiterate | Buy → Buy | $24 | 52% |
| Nov 7, 2025 | Truist Securities | reiterate | Buy → Buy | $20 | 54% |
| Nov 7, 2025 | BTIG | maintain | Buy → Buy | $24 | 52% |
| Aug 18, 2025 | Truist Securities | initiate | — → Buy | $18 | 54% |
| Aug 18, 2025 | Goldman Sachs | initiate | — → Buy | $19 | 54% |
| Aug 18, 2025 | Piper Sandler | initiate | — → Overweight | $18 | 54% |
Price Target Trend
Apr 22, 2026 Oct 26, 2026
EPS Estimates
+1y —
0y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days